-Search query
-Search result
Showing all 46 items for (author: gristick & hb)
EMDB-26491:
Cryo-EM structure of BG24 inferred germline Fabs with germline CDR3s and 10-1074 Fabs in complex with HIV-1 Env immunogen BG505-SOSIPv4.1-GT1 - Class 2
Method: single particle / : Dam KA, Bjorkman PJ
EMDB-26494:
Cryo-EM map of BG24 Fabs with an inferred germline light chain and 10-1074 Fabs in complex with HIV-1 Env immunogen BG505-SOSIPv4.1-GT1 containing the N276 gp120 glycan- Class 2
Method: single particle / : Dam KA, Bjorkman PJ
EMDB-26495:
Cryo-EM map of BG24 Fabs with an inferred germline light chain and 10-1074 Fabs in complex with HIV-1 Env immunogen BG505-SOSIPv4.1-GT1 containing the N276 gp120 glycan- Class 3
Method: single particle / : Dam KA, Bjorkman PJ
EMDB-26493:
Cryo-EM structure of BG24 Fabs with an inferred germline light chain and 10-1074 Fabs in complex with HIV-1 Env immunogen BG505-SOSIPv4.1-GT1 containing the N276 gp120 glycan- Class 1
Method: single particle / : Dam KA, Bjorkman PJ
EMDB-26496:
Cryo-EM structure of BG24 Fabs with an inferred germline CDRL1 and 10-1074 Fabs in complex with HIV-1 Env 6405-SOSIP.664
Method: single particle / : Dam KA, Bjorkman PJ
EMDB-26490:
Cryo-EM structure of BG24 inferred germline Fabs with germline CDR3s and 10-1074 Fabs in complex with HIV-1 Env immunogen BG505-SOSIPv4.1-GT1 - Class 1
Method: single particle / : Dam KA, Bjorkman PJ
EMDB-26492:
Cryo-EM structure of BG24 inferred germline Fabs with mature CDR3s and 10-1074 Fabs in complex with HIV-1 Env immunogen BG505-SOSIPv4.1-GT1
Method: single particle / : Dam KA, Bjorkman PJ
EMDB-24853:
Modified BG505 SOSIP-based immunogen RC1 in complex with elicited mAb Ab283MUR Fab and 8ANC195 Fab
Method: single particle / : Abernathy ME, Bjorkman PJ
EMDB-24854:
Modified BG505 SOSIP-based immunogen RC1 in complex with elicited mAb Ab1170NHP Fab and 8ANC195 Fab
Method: single particle / : Abernathy ME, Bjorkman PJ
EMDB-24855:
Modified BG505 SOSIP-based immunogen RC1 in complex with Rabbit 2249 post-Prime polyclonal Fabs
Method: single particle / : Barnes CO, DeLaitsch AT, Bjorkman PJ
EMDB-24856:
Modified BG505 SOSIP-based immunogen RC1 in complex with Rabbit 2249 post-Boost 1 polyclonal Fabs
Method: single particle / : DeLaitsch AT, Barnes CO, Bjorkman PJ
EMDB-24857:
Modified BG505 SOSIP-based immunogen RC1 in complex with Rabbit 2249 post-Boost 2 polyclonal Fabs
Method: single particle / : DeLaitsch AT, Barnes CO, Bjorkman PJ
EMDB-24858:
Modified BG505 SOSIP-based immunogen RC1 in complex with Rabbit 2249 post-Boost 3 polyclonal Fabs
Method: single particle / : DeLaitsch AT, Barnes CO, Bjorkman PJ
EMDB-24859:
Modified BG505 SOSIP-based immunogen RC1 in complex with Rabbit 2249 post-Boost 4 polyclonal Fabs
Method: single particle / : DeLaitsch AT, Barnes CO, Bjorkman PJ
EMDB-24860:
Modified BG505 SOSIP-based immunogen RC1 in complex with NHP 1 post-Prime polyclonal Fabs
Method: single particle / : DeLaitsch AT, Barnes CO, Bjorkman PJ
EMDB-24861:
Modified BG505 SOSIP-based immunogen RC1 in complex with NHP 1 post-Boost 1 polyclonal Fabs
Method: single particle / : DeLaitsch AT, Barnes CO, Bjorkman PJ
EMDB-25878:
Cryo-EM structure of HIV-1 Env trimer BG505 SOSIP.664 in complex with CD4bs antibody Ab1573
Method: single particle / : Yang Z, Bjorkman PJ
EMDB-25877:
Cryo-EM structure of CD4bs antibody Ab1303 in complex with HIV-1 Env trimer BG505 SOSIP.664
Method: single particle / : Yang Z, Bjorkman PJ
EMDB-24072:
Ab1245 Fab in complex with BG505 SOSIP.664 and 8ANC195 Fab
Method: single particle / : Abernathy ME, Bjorkman PJ
EMDB-22820:
BG505 SOSIP.664 in complex with the V3-targeting rhesus macaque antibody 1485 and human gp120-gp41 interface antibody 8ANC195
Method: single particle / : Barnes CO, Bjorkman PJ
EMDB-22729:
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C002 (state 1)
Method: single particle / : Barnes CO, Malyutin AG, Bjorkman PJ
EMDB-22730:
Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, C002 (State 2)
Method: single particle / : Malyutin AG, Barnes CO, Bjorkman PJ
EMDB-22731:
Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, C104
Method: single particle / : Barnes CO, Malyutin AG, Bjorkman PJ
EMDB-22732:
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C110
Method: single particle / : Dam KA, Barnes CO, Bjorkman PJ
EMDB-22733:
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C119
Method: single particle / : Sharaf NG, Barnes CO, Bjorkman PJ
EMDB-22734:
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C121 (State 1)
Method: single particle / : Abernathy ME, Barnes CO, Bjorkman PJ
EMDB-22735:
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C121 (State 2)
Method: single particle / : Abernathy ME, Barnes CO, Bjorkman PJ
EMDB-22736:
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C135
Method: single particle / : Barnes CO, Bjorkman PJ
EMDB-22737:
Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, C144
Method: single particle / : Barnes CO, Esswein SR, Bjorkman PJ
EMDB-22124:
SARS-CoV-2 S 2P negative-stain EM
Method: single particle / : Barnes CO, Bjorkman PJ
EMDB-22125:
SARS-CoV-2 S 2P trimer complexed with COV57 polyclonal Fabs
Method: single particle / : Barnes CO, Bjorkman PJ
EMDB-22126:
SARS-CoV-2 S 2P trimer complexed with polyclonal Fabs from recovered COVID-19 individual COV21
Method: single particle / : Barnes CO, Bjorkman PJ
EMDB-22127:
Structure of the SARS-CoV-2 spike glycoprotein in complex with the C105 neutralizing antibody Fab fragment (state 1)
Method: single particle / : Barnes CO, Bjorkman PJ
EMDB-22128:
Structure of the SARS-CoV-2 spike glycoprotein in complex with the C105 neutralizing antibody Fab fragment (state 2)
Method: single particle / : Barnes CO, Bjorkman PJ
EMDB-20739:
HIV-1 bNAb 1-18 in complex with BG505 SOSIP.664 and 10-1074
Method: single particle / : Abernathy ME, Barnes CO, Gristick HB, Bjorkman PJ
EMDB-20740:
HIV-1 bNAb 1-55 in complex with modified BG505 SOSIP-based immunogen RC1 and 10-1074
Method: single particle / : Abernathy ME, Barnes CO, Gristick HB, Bjorkman PJ
EMDB-21204:
BG505 SOSIP in complex with antibodies BG1 and 8ANC195
Method: single particle / : Wang H, Bjorkman PJ
EMDB-20605:
Asymmetrically open conformational state (Class I) of HIV-1 Env trimer BG505 SOSIP.664 in complex with sCD4 and E51 Fab
Method: single particle / : Yang Z, Bjorkman PJ
EMDB-20608:
Asymmetrically open conformational state (Class II) of HIV-1 Env trimer BG505 SOSIP.664 in complex with sCD4 and E51 Fab
Method: single particle / : Yang Z, Bjorkman PJ
EMDB-20175:
Modified BG505 SOSIP-based immunogen RC1 in complex with the elicited V3-glycan patch bNAb 10-1074
Method: single particle / : Abernathy ME, Gristick HB, Bjorkman PJ
EMDB-20176:
Modified BG505 SOSIP-based immunogen RC1 in complex with the elicited V3-glycan patch antibody Ab874NHP
Method: single particle / : Abernathy ME, Gristick HB, Bjorkman PJ
EMDB-20177:
Modified BG505 SOSIP-based immunogen RC1 in complex with the elicited V3-glycan patch antibody Ab897NHP
Method: single particle / : Abernathy ME, Gristick HB, Bjorkman PJ
EMDB-20178:
Modified BG505 SOSIP-based immunogen RC1 in complex with the elicited V3-glycan patch antibody Ab275MUR
Method: single particle / : Abernathy ME, Gristick HB, Bjorkman PJ
EMDB-8693:
BG505 SOSIP.664 in complex with broadly neutralizing antibodies BG1 and 8ANC195
Method: single particle / : Wang H, Bjorkman PJ
EMDB-8695:
BG505 SOSIP.664 in complex with broadly neutralizing antibodies PG9 and 8ANC195
Method: single particle / : Wang H, Bjorkman PJ
EMDB-8407:
Cryo-EM structure of a BG505 Env-sCD4-17b-8ANC195 complex
Method: single particle / : Wang H, Bjorkman PJ